| Literature DB >> 15304515 |
Christel Schwegmann-Wessels1, Marwan Al-Falah, David Escors, Zai Wang, Gert Zimmer, Hongkui Deng, Luis Enjuanes, Hassan Y Naim, Georg Herrler.
Abstract
Coronaviruses (CoV) mature by a budding process at intracellular membranes. Here we showed that the major surface protein S of a porcine CoV (transmissible gastroenteritis virus) is not transported to the cell surface but is retained intracellularly. Site-directed mutagenesis indicated that a tyrosine-dependent signal (YXXI) in the cytoplasmic tail is essential for intracellular localization of the S protein. Surface expression of mutant proteins was evident by immunofluorescence analysis and surface biotinylation. Intracellularly retained S proteins only contained endoglycosidase H-sensitive N-glycans, whereas mutant proteins that migrated to the plasma membrane acquired N-linked oligosaccharides of the complex type. Corresponding tyrosine residues are present in the cytoplasmic tails of the S proteins of other animal CoV but not in the tail portion of the S protein of severe acute respiratory syndrome (SARS)-CoV. Changing the SEPV tetrapeptide in the cytoplasmic tail to YEPI resulted in intracellular retention of the S protein of SARS-CoV. As the S proteins of CoV have receptor binding and fusion activities and are the main target of neutralizing antibodies, the differences in the transport behavior of the S proteins suggest different strategies in the virus host interactions between SARS-CoV and other coronaviruses.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15304515 PMCID: PMC8060824 DOI: 10.1074/jbc.M407233200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157
Primers used for plasmid constructions
| Oligonucleotide | 5′-Sequence-3′ |
|---|---|
| a | TTTGAATTCCACACCATGAAAAAACTATTTGTGGTTTTGG |
| b | TTTTCTGCAGTTAATGGACGTGCACTTTTTCAATTGG |
| c | CTAGATGACAAGTTCTATTTGACCC |
| d | GAGGATTTTCCGTGCTTTTTCAAGATTGACTAATGTATTGTTAATGTT |
| e | ACATTAGTCAATCTTGAAAAAGCACGGAAAATCCTCTCTGAGGTAGG |
| f | TTTTCTGCAGTCATCTTTTCTCAGCCATCGCATC |
| g | ATTTTCAAATTGTCTTCTATAAAGCACGATGACGATCACTATAATGACC |
| h | ATCGTCATCGTGCTTTATAGAAGACAATTTGAAAATTACGAACCA |
| i | CATTGACCTTTTGAGTCTACTACATATAGAGTGACAACAACTTCCTAA |
| j | TGTCACTCTATATGTAGTAGACTCAAAAGGTCAATGCTAATGGGTAAT |
| n | ATTTGAAAATGCCGAACCAATTGAA |
| o | CAATTGGTTCGGCATTTTCAAATTGT |
| p | TGAAAATTACGCCCCAATTGAAAAAG |
| q | TTTCAATTGGGGCGTAATTTTCAAAT |
| r | AAATTACGAAGCCATTGAAAAAGTG |
| s | CTTTTTCAATGGCTTCGTAATTTTC |
| t | TTACGAACCAGCCGAAAAAGTGCAC |
| u | GCACTTTTTCGGCTGGTTCGTAATT |
| v | CGAACCAATTGCCAAAGTGCACGTC |
| w | CGTGCACTTTGGCAATTGGTTCGTA |
| A | TTTTGAATTCATGTTTATTTTCTTATTATTTCTTACTCTCACTAGTGG |
| B | TTTTGGATCCTTATGTGTAATGTAATTTGACACCCTTGAG |
| C | GTTAACCAGAATGCTCAAGCATTAA |
| D | TGAGGATGACTACGAGCCAGTTCTC |
| E | GAACTGGCTCGTAGTCATCCTCATCA |
| F | TGAGGATGACTACGAGCCAATCCTCAAGGGTGTC |
| G | CACCCTTGAGGATTGGCTCGTAGTCATCCTCATC |
FSchematic drawing of TGEV-S and SeV-F chimeras (,,) as well as TGEV-S () and SARS-CoV-S parental and mutant proteins. TGEV-S sequences are indicated by open boxes, SeV-F sequences are indicated by dotted boxes, and SARS-CoV-S sequences are indicated by gray boxes. It should be noted that the sizes of the boxes are not proportional to the length of the amino acid chain. The carboxyl-terminal domain of TGEV-S only comprises 16 and of SARS-CoV-S 19 amino acids, whereas the tail of the F protein is 42 amino acids in length. The initial and terminal amino acids are shown once for each domain. Letters above arrows indicate the primers used for cloning (see Table I).
FSurface and intracellular () immunofluorescence analysis of parental TGEV-S () and TGEV-S/SeV-F chimeras (,,). BSR-T7/5 cells were transfected with the pTM1 expression plasmid containing the gene indicated. Cells were analyzed for surface and intracellular expression of the indicated proteins at 24 h post-transfection by immunofluorescence microscopy.
FSurface and intracellular () immunofluorescence analysis of TGEV-S mutants (the amino acid exchange and position is indicated). BSR-T7/5 cells were transfected with the pTM1 expression plasmid containing the gene indicated. Cells were analyzed for surface and intracellular expression of the indicated proteins at 24 h post-transfection by immunofluorescence microscopy.
FTGEV-S parental, mutant, and chimeric proteins were expressed and analyzed by surface biotinylation () or Western blot (). BSR-T7/5 cells were transfected with the pTM1 expression plasmid containing either of the following TGEV-S genes, a, SSS; b, SFF; c, SFS; d, SSF; e, Y1440A; f, E1441A; g, P1442A; h, I1443A; i, E1444A; j, mock-transfected cells. At 24 h post-transfection cells were prepared for surface biotinylation or Western blot.
FEffect of endoglycosidase treatment on parental () and chimeric () TGEV S protein. Transfected BSR-T7/5 cells were radiolabeled and prepared for treatment with endoglycosidases. Samples were incubated with endoglycosidase H (H), N-glycosidase F (F), or in the absence of enzyme (–).
FSurface and intracellular () immunofluorescence analysis of parental or mutant proteins of SARS-CoV-S. BSR-T7/5 cells were transfected with the pTM1 expression plasmid containing the gene indicated. Applying immunofluorescence microscopy, cells were analyzed for surface and intracellular expression of the respective protein at 24 h post-transfection.